नाइजीरिया - अंग्रेज़ी - NAFDAC (National Agency for Food and Drugs Administration and Control)

ceftriaxone sodium 1g + lidocaine 5ml + water for injection 5ml

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

apotheca marketing pte ltd - ceftriaxone disodium eqv ceftriaxone - injection, powder, for solution - 1 g/vial - ceftriaxone disodium eqv ceftriaxone 1 g/vial

दक्षिण अफ़्रीका - अंग्रेज़ी - South African Health Products Regulatory Authority (SAHPRA)

pharmacare limited û woodmead - injection - see ingredients - each vial contains cefepime hydrochloride equivalent to cefepime 1,0 g

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

n/a; importer: ambica international corporation; distributor: diafarm inc. - ceftriaxone (as sodium) - powder for injection (im/iv) - 1 g

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

dynasty pharmaceuticals; distributor: dynasty pharmaceuticals - ceftriaxone (as sodium) - powder for injection (im/iv) - 1g

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

n/a; importer: greencore pharma inc.; distributor: triple tact import & export corp - ceftazidime (as pentahydrate) - powder for injection (im/iv) - 1 g

नामीबिया - अंग्रेज़ी - Namibia Medicines Regulatory Council

pharmacare limited (pty) ltd - cefepime hydrochloride - powder for injection - each vial contains; cefepime hydrochloride equivalent to cefepime 1,000 mg

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

zakir & zaheer paragon trading, inc; distributor: zakir & zaheer paragon trading, inc - ceftriaxone (as sodium) - powder for injection (im/iv) - 1 g

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

n/a; importer: euro-care products philippines; distributor: asianmeds, inc. - cefuroxime (as sodium) - powder for injection (i.m./i.v.) - 750 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

asm aerosol-service ag - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - clenpiq is indicated for cleansing of the colon as a preparation for colonoscopy in adults. clenpiq is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute), which may result in accumulation of magnesium [see warnings and precautions (5.3)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in clenpiq risk summary there are no data with clenpiq use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. in animal reproduction studies, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1.2 times the recommended human dose based on body surface area during organogenesis. the estimated background risk of major